AGM
DMK

Alpine Global Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Alpine Global Management’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-195
Closed -$31K – 223
2018
Q4 		$31K Buy
+195
New +$37.4K 0.01% 227
2018
Q1 		– Sell
-330
Closed -$102K – 204
2017
Q4 		$102K Buy
+330
New +$109K 0.02% 155

Other funds holding DMK

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Alpine Global Management's DMK Position: Q1 2019 in Review

Alpine Global Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2019, closing a stake of 195 shares — an estimated $31K sold.

Alpine Global Management first reported a position in DMK in Q4 2017 and held it in 2 quarters. The position peaked at $102K in Q4 2017. 57 funds tracked by Wall St. Rank hold DMK as of Q1 2019.

  • Alpine Global Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2019 after selling out during the quarter.
  • Alpine Global Management sold 195 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2019, an estimated $31K.
  • Alpine Global Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2017 and held it in 2 quarters.
  • Alpine Global Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $102K in Q4 2017.
  • 57 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2019.

Based on Alpine Global Management's 13F filing for Q1 2019, filed 10 May 2019.